
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, outlines why faster recruitment, local data requirements for registration, and lower costs make APAC attractive for global Phase III programs.
Lucille Coassin, Sr. Dir Pharma Partnerships, Current Health Discusses Connected Device Patient Monitoring






